An old drug for a new disease: Pentostatin (Nipent) in acute graft- versus-host disease

Medicine and Dentistry

• Disease 100%
• Acute Graft Versus Host Disease 100%
• Pentostatin 100%
• Graft Versus Host Reaction 75%
• Immunosuppressive Drug 50%
• Chronic Graft Versus Host Disease 50%
• Bone Marrow Transplantation 50%
• Mortality Rate 25%
• Lymphocyte 25%
• Oncology 25%
• Anticarcinogen 25%
• Immune System 25%
• Hematologic Malignancy 25%
• Allogenic Bone Marrow Transplantation 25%

Keyphrases

• New Disease 100%
• Graft-versus-host Disease (GvHD) 100%
• Pentostatin 100%
• Old Drugs 100%
• Bone Marrow Transplantation 25%
• Mortality Rate 12%
• Hematological Malignancies 12%
• Therapeutic Potential 12%
• Johns Hopkins 12%
• Immune System 12%
• Moderate to Severe 12%
• Median Survival 12%
• Antineoplastic Agents 12%
• Severe Acute 12%
• Immunomodulatory Effect 12%
• Allogeneic Bone Marrow Transplantation 12%
• Oncology Center 12%
• Failure Rate 12%
• Lymphocyte Count 12%
• Immunosuppressive Properties 12%
• Lymphocyte Function 12%
• 10-year Mortality 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Pentostatin 100%
• Acute Graft Versus Host Disease 100%
• Graft Versus Host Reaction 75%
• Immunosuppressive Agent 50%
• Chronic Graft Versus Host Disease 50%
• Anticarcinogen 25%
• Mortality Rate 25%
• Hematologic Malignancy 25%